SEC Form 4 · accession 0001140361-15-010312
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel K Spiegelman
Officer — EVP, Chief Financial Officer
Period of report
Mar 2, 2015
Accepted (ET)
Mar 4, 2015 · 7:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 2, 2015 | M | 15,500 | $39.06 | A | 84,176 | D | |
| Common StockF1 | Mar 2, 2015 | S | 15,500 | $107.00 | D | 68,676 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy Common Stock)F3,F2 | $39.06 | Mar 2, 2015 | M | 15,500 | D | Nov 29, 2012 | May 28, 2022 | Common Stock | 15,500 | 39,500 | D |
Explanation of responses
- F1All shares sold at same price.
- F2Option grant vests 6/48ths on November 29, 2012 and 1/48th on the 29th day of every month thereafter.
- F3Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.